Search

Purpose:Intensity-modulated radiotherapy (IMRT) is currently the most important treatment method for nasopharyngeal carcinoma (NPC). This study aimed to enhance prediction accuracy by incorporating dose information into a deep convolutional neural network (CNN) using a multichannel input method. Methods:A target conformal plan (TCP) was created based on the maximum planning target volume (PTV). Input data included TCP dose distribution, images, target structures, and organ-at-risk (OAR) information. The role of target conformal plan dose (TCPD) was assessed by comparing the TCPD–CNN (with dose information) and NonTCPD–CNN models (without dose information) using statistical analyses with the ranked Wilcoxon test (P< .05 considered significant). Results:The TCPD–CNN model showed no statistical differences in predicted target indices, except for PTV60, where differences in the D98% indicator were < 0.5%. For OARs, there were no significant differences in predicted results, except for some small-volume or closely located OARs. On comparing TCPD–CNN and NonTCPD–CNN models, TCPD–CNN's dose-volume histograms closely resembled clinical plans with higher similarity index. Mean dose differences for target structures (predicted TCPD–CNN and NonTCPD–CNN results) were within 3% of the maximum prescription dose for both models. TCPD–CNN and NonTCPD–CNN outcomes were 67.9% and 54.2%, respectively. 3D gamma pass rates of the target structures and the entire body were higher in TCPD–CNN than in the NonTCPD–CNN models (P< .05). Additional evaluation on previously unseen volumetric modulated arc therapy plans revealed that average 3D gamma pass rates of the target structures were larger than 90%. Conclusions:This study presents a novel framework for dose distribution prediction using deep learning and multichannel input, specifically incorporating TCPD information, enhancing prediction accuracy for IMRT in NPC treatment.

To test the basic dosimetry characteristics of a new high-resolution matrix and to perform a preliminary study on the three-dimensional (3D) dose verification of intensity-modulated treatment (IMRT).